Yacine Saïdi

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

Anna Turkova, Ellen White, Cissy Kityo et al. · UCL Discovery (University College London) · 2021 · 103 citations

Pharmacy, Pediatrics, Pharmacotherapy +16

On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial

Guillemette Antoni, Cécile Tremblay, Constance Delaugerre et al. · The Lancet HIV · 2019 · 79 citations

Public Health, Pharmacology, Pharmacotherapy +17

Current management of late onset neonatal bacterial sepsis in five European countries

Irja Lutsar, Corine Chazallon, Francesca Ippolita Calò Carducci et al. · European Journal of Pediatrics · 2014 · 49 citations

Medicine, Infectious Diseases, Pediatrics +16

Adherence to Antiretroviral Therapy and Outcomes in HIV-Infected Patients Enrolled in An Induction/Maintenance Randomized Trial

Philippe Flandre, Gilles Peytavin, Vincent Meiffrédy et al. · Antiviral Therapy · 2002 · 35 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Pauline Amuge, Abbas Lugemwa, Ben Wynne et al. · The Lancet HIV · 2022 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pediatrics +15